ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease
- DOI
- 10.1038/s41523-023-00512-7
- Published
- 2023-03-06
- Container
- npj Breast Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41523-023-00512-7,
title = {ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease},
author = {Shane R. Stecklein and Bruce F. Kimler and Rachel Yoder and Kelsey Schwensen and Joshua M. Staley and Qamar J. Khan and Anne P. O’Dea and Lauren E. Nye and Manana Elia and Jaimie Heldstab and Trisha Home and Stephen Hyter and Kamilla Isakova and Harsh B. Pathak and Andrew K. Godwin and Priyanka Sharma},
year = {2023},
journal = {npj Breast Cancer},
doi = {10.1038/s41523-023-00512-7},
url = {https://doi.org/10.1038/s41523-023-00512-7}
}RIS
TY - JOUR TI - ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease AU - Shane R. Stecklein AU - Bruce F. Kimler AU - Rachel Yoder AU - Kelsey Schwensen AU - Joshua M. Staley AU - Qamar J. Khan AU - Anne P. O’Dea AU - Lauren E. Nye AU - Manana Elia AU - Jaimie Heldstab AU - Trisha Home AU - Stephen Hyter AU - Kamilla Isakova AU - Harsh B. Pathak AU - Andrew K. Godwin AU - Priyanka Sharma PY - 2023 JO - npj Breast Cancer DO - 10.1038/s41523-023-00512-7 UR - https://doi.org/10.1038/s41523-023-00512-7 ER -
APA
Stecklein, S. R., Kimler, B. F., Yoder, R., Schwensen, K., Staley, J. M., Khan, Q. J., O’Dea, A. P., Nye, L. E., Elia, M., Heldstab, J., Home, T., Hyter, S., Isakova, K., Pathak, H. B., Godwin, A. K., & Sharma, P. (2023). ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. npj Breast Cancer. https://doi.org/10.1038/s41523-023-00512-7
Source records
- crossref · retrieved 2026-11-07T04:12:05.998Z